The combination of metabolic syndrome and inflammation increased the risk of colorectal cancer

ConclusionsWe found the combination of MetS and inflammation could significantly increase the risk of CRC. Including CRP in the diagnosis of MetS may help to identify additional high-risk participants who should be targeted for early diagnosis and prevention of CRC.Trial registrationKailuan study, ChiCTR –TNRC–11001489. Registered 24 August, 2011-Retrospectively registered, http://www.chictr.org.cn/showprojen.aspx?proj=8050
Source: Inflammation Research - Category: Research Source Type: research